A third presenter, Christopher Willett, M.D., of Duke University, discussed his clinical team's use of RapidArc® technology to deliver precise image-guided treatments quickly by delivering the dose continuously from 360 degrees around the patient while shaping the treatment beam to match the shape of the tumor from every angle. RapidArc makes it possible to complete an image-guided treatment two to eight times faster than is possible with conventional approaches to beam delivery.
"Varian Medical Systems has a corporate mission of helping radiation oncology professionals to save another 100,000 lives every year," said Thomas P. Duffy, Varian's vice president of sales and marketing for the Asia Pacific region. "To that end, we are committed to supporting the clinical adoption of advanced forms of radiotherapy across China. We sponsored this symposium as part of our commitment to facilitating the transfer of best clinical practices between the east and the west."
Ad Statistics
Times Displayed: 22183
Times Visited: 440 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
ABOUT VARIAN MEDICAL SYSTEMS
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X- ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,100 people who are located at manufacturing sites in North America, Europe, and China and approximately 79 sales and support offices around the world. For more information, visit http://www.varian.com.
(1) Published papers on this topic:
Blomgren H et al. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol. 1995;34:861-870.
Chang J et al. Stereotactic Body Radiation Therapy in Centrally and Superiorly Located Stage I or Isolated Recurrent Non-Small-Cell Lung Cancer. International Journal of Radiation Oncology * Biology * Physics, 15 November 2008 (Vol. 72, Issue 4, Pages 967-971.
Lagerwaard F et al. Outcomes of Risk-Adapted Fractionated Stereotactic Radiotherapy for Stage I Non-Small-Cell Lung Cancer. International Journal of Radiation Oncology * Biology * Physics, 1 March 2008 (Vol. 70, Issue 3, Pages 685-692).
